Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

22 projects found matching your search criteria :

  1. Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m...

    Call: HARMONIA 6 , Panel: NZ5

    Principal investigator: dr Tomasz Stokłosa

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  2. Mechanism of SYK-mediated suppression of differentiation and apoptosis in acute myeloid leukemia (AML)

    Call: PRELUDIUM 6 , Panel: NZ5

    Principal investigator: dr Anna Polak

    Instytut Hematologii i Transfuzjologii

  3. The regulation of vitamin D receptor expression by retinoids

    Call: PRELUDIUM 6 , Panel: NZ3

    Principal investigator: Aleksandra Marchwicka

    Uniwersytet Wrocławski, Wydział Biotechnologii

  4. Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Flis

    Narodowy Instytut Leków

  5. The role of nucelophosmin-1 exon 12 abnormalities in acute myeloid leukemias and myelodyplastic syndrome

    Call: HARMONIA 5 , Panel: NZ5

    Principal investigator: dr hab. Krzysztof Giannopoulos

    Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

  6. Investigation of the molecular mechanisms of anti-leukemic activity of SK053, a small molecule compound targeting enzyme...

    Call: SONATA BIS 3 , Panel: NZ5

    Principal investigator: prof. Dominika Nowis

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  7. Investigation of the role of ficolins in anti-microbial defense in patients suffering from acute myeloid leukaemia, unde...

    Call: PRELUDIUM 4 , Panel: NZ6

    Principal investigator: Anna Sokołowska

    Instytut Biologii Medycznej PAN

  8. The novel role of CD44 protein in the bone marrow microenvironment-mediated metabolic remodeling of chronic myeloid leuk...

    Call: PRELUDIUM 22 , Panel: NZ3

    Principal investigator: Laura Turos-Korgul

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  9. Differences in the glycoproteomic profile of acute myeloid leukemia (AML) between cytogenetic and risk groups according ...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Tomasz Pieńkowski

    Uniwersytet Medyczny w Białymstoku

  10. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a...

    Call: PRELUDIUM BIS 4 , Panel: NZ5

    Principal investigator: prof. Ewa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  11. Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr hab. Carlo Vascotto

    Instytut Hematologii i Transfuzjologii

  12. Verification of personalized therapeutic strategy based on Integrated Stress Response inhibition for myeloid neoplasms w...

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  13. Identifying the hematopoietic and leukemic stem cell niches

    Call: MOZART 1 , Panel: NZ3

    Principal investigator: dr Krzysztof Szade

    Uniwersytet Jagielloński

  14. Linking stress response with genomic instability in chronic myeloid leukaemia cells; role of the PERK-eIF2α phosphorylat...

    Call: OPUS 1 , Panel: NZ3

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  15. Epigenetic effect on therapeutic activities of all-trans-retinoic acid in acute myeloid leukemia

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: prof. Arthur Zelent

    Wojskowy Instytut Higieny i Epidemiologii im. gen. Karola Kaczkowskiego

  16. Immunological and molecular characteisitics of chronic myeloid leukemia patients after stopping imatinib

    Call: OPUS 16 , Panel: NZ6

    Principal investigator: prof. Krzysztof Giannopoulos

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

  17. Deciphering molecular mechanism of CDK8 kinase inhibitors action in acute myeloid leukemia

    Call: SONATA BIS 8 , Panel: NZ2

    Principal investigator: dr hab. Michał Mikula

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

  18. Tracing the roots of leukemia - how preleukemic hematopoietic stem cells contribute to acute lymphoid and myeloid leukem...

    Call: HARMONIA 10 , Panel: NZ5

    Principal investigator: dr Krzysztof Szade

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  19. Determining the role of basigin in multiple myeloma and acute myeloid leukaemia development

    Call: PRELUDIUM 15 , Panel: NZ5

    Principal investigator: Piotr Łacina

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  20. Phosphorylation of translation initiation factor eIF2alpha as regulator of synthesis of proinflammatory and signaling cy...

    Call: PRELUDIUM 10 , Panel: NZ3

    Principal investigator: Wioleta Dudka-Ruszkowska

    Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

  21. Characterization of aberrant mechanisms of telomere maintenance in chronic myeloid leukemia - the role of POT1 and RAP1 ...

    Call: OPUS 10 , Panel: NZ5

    Principal investigator: dr Tomasz Stokłosa

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  22. Products of DNA demethylation and deamination pathways as new biomarkers of development and predictors of the outcome in...

    Call: OPUS 10 , Panel: NZ5

    Principal investigator: dr hab. Daniel Gackowski

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny